Blog Read the latest perspectives from our team of subject matter experts and others Aligning Incentives for Clinical Trials in the Age of AIAt SCOPE Summit US, Ariel Katz, CEO and Co-founder of H1, sat down with Robert Stevens, Head of Clinical Development Procurement at Bristol Myers Squibb, for a candid conversation about… Continue reading → Read the article Post Topics:Artificial Intelligence Commercialization Drug Development Global Impact KOL Engagement Patient Representation Provider Data Post Industries:Digital Health Health Plans Pharmaceutical & Biotechnology Sorry! No posts found for the applied filter.
